Remove 2028 Remove Pharmaceuticals Remove Therapies Remove Vaccine
article thumbnail

Where are the global hotspots for biotech?

Drug Discovery World

Who: The US is home to the majority of the top 20 biotechnology companies, including Amgen, Gilead Sciences, Thermo Fisher Scientific, Vertex Pharmaceuticals and Regeneron Pharmaceuticals. The company is now pursuing a pipeline of mRNA vaccines for cancer, several of which are at the Phase II stage.

article thumbnail

Can Singapore become a global hub for biotech?

Drug Discovery World

According to Statista, revenue in this sector is expected to grow at an annual rate of 6.77%, resulting in a market volume of US$2,208m by 2028 1. Singapore is among a few countries worldwide whose pharmaceutical export value far exceed the import value. UK-based molecular diagnostics group Yourgene operates in Singapore.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

India: Why is the country ramping up drug discovery research?

Drug Discovery World

In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. Similarly, The Times of India says that branded generic medicines have “long fuelled India’s pharmaceutical exports” 4.

Research 130
article thumbnail

Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas

The Pharma Data

27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame. Major revenue contributions through 2025 anticipated from Oncology, Vaccines, Rare Disease and Inflammation and Immunology. BNT162 mRNA-based Vaccine Program.

Vaccine 52